Cardiology

Results from the PARTNER II trial show improvements in 30-day mortality and stroke rates in patients with aortic stenosis who are not surgical candidates who were treated using a newer version of the Sapien transcatheter aortic valve replacement system.

Landmark study results presented at ACC.13 reveal patients with vascular disease treated with niacin therapy face increased risk of myopathy and other adverse events.

Results of the ARMYDA-9 CAROTID trial indicate that loading with 600 mg clopidogrel and high-dose atorvastatin in carotid stent patients independently result in improved neurological outcomes.

Study results presented at ACC.13, the 62nd Annual Scientific Session & Expo of the American College of Cardiology, reveal that in selected STEMI patients, deferred stenting may reduce no-reflow and thrombotic events compared with immediate stenting.

Though two new blood clot removal devices only recently received FDA approval for clinical use, specialists at the Stony Brook University Cerebrovascular and Stroke Center have already seen improved outcomes in acute ischemic stroke patients after performing endovascular treatments with both advanced technologies.

Bioengineers at the University of California, San Diego have deemed a new injectable hydrogel safe and effective for repairing tissue damage caused by myocardial infarction, providing a platform to bring the gel to clinical trials within the next year.

After finding abnormal elevations of cardiac inflammation in patients with depressive illness (DI), a psychiatrist at Loyola University Medical Center, in Maywood, Ill., has proposed a new subspecialty to diagnose and treat patients with both depression and cardiovascular disease (CVD).

A roundup of recently published articles on the assessment, diagnosis, and management of hyponatremia in a variety of patient populations and clinical settings.

Research into prognostic models that focus on serum sodium levels in an effort to identify patients awaiting liver transplant who may be at higher risk of poor outcomes have been inconclusive.

Many widely held beliefs about obesity and weight loss have no scientific basis.

Use of blood volume analysis can help clinicians more accurately identify contributing factors to hyponatremia and avoid contraindicated interventions.

The American Diabetes Association revised Standards of Medical Care for patients with diabetes include several changes in recommendations regarding testing and treatment goals.